Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Most view

Page Path
HOME > Articles and issues > Most view
108 Most view
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles

Most-read articles are from the articles published in 2021 during the last three month.

Original Article
mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea
Hanul Park, Young Joon Park, Sang Eun Lee, Min Jei Lee, Hyungtae Ahn
Osong Public Health Res Perspect. 2022;13(6):435-442.   Published online November 28, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0243
  • 2,353 View
  • 119 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
Household contacts of confirmed cases of coronavirus disease 2019 (COVID-19) areexposed to a high risk of viral transmission, and secondary incidence is an important indicatorof community transmission. This study analyzed the secondary attack rate and mRNA vaccineeffectiveness against transmission (VET) for index cases (patients treated at home) confirmedto be infected with the Delta and Omicron variants.Methods: The subjects of the study were 4,450 index cases and 10,382 household contacts.Logistic regression analysis was performed to compare the secondary attack rate byvaccination status, and adjusted relative risk and 95% confidence intervals were identified.Results: The secondary attack rate of the Delta variant was 27.3%, while the secondary attackrate of the Omicron variant was 29.8%. For the Delta variant, groups with less than 90 daysand more than 90 days after 2 doses of mRNA vaccination both showed a VET of 37%. For theOmicron variant, a 64% VET was found among those with less than 90 days after 2 doses ofmRNA vaccination.Conclusion: This study provides useful data on the secondary attack rate and VET of mRNAvaccines for household contacts of COVID-19 cases in South Korea.
Brief Report
The effectiveness of Paxlovid treatment in long-term care facilities in South Korea during the outbreak of the Omicron variant of SARS-CoV-2
Hanul Park, Young Joon Park, Hye Young Lee, Mi Yu, Yeong-Jun Song, Sang Eun Lee, Ji-Joo Lee, Eun-Sol Lee, Yeonjung Kim
Osong Public Health Res Perspect. 2022;13(6):443-447.   Published online December 23, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0262
  • 1,239 View
  • 123 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
On November 5, 2021, Pfizer Inc. announced Paxlovid (nirmatrelvir +ritonavir) asa treatment method that could reduce the risk of hospitalization or death for patients withconfirmed coronavirus disease 2019 (COVID-19).Methods: From February 6, 2022 to April 2, 2022, the incidence of COVID-19 and the effectsof treatment with Paxlovid were analyzed in 2,241 patients and workers at 5 long-term carefacilities during the outbreak of the Omicron variant of severe acute respiratory syndromecoronavirus 2 in South Korea.Results: The rate of severe illness or death in the group given Paxlovid was 51% lower thanthat of the non-Paxlovid group (adjusted risk ratio [aRR], 0.49; 95% confidence interval [CI],0.24−0.98). Compared to unvaccinated patients, patients who had completed 3 doses of thevaccine had a 71% reduced rate of severe illness or death (aRR, 0.29; 95% CI, 0.13−0.64) and a65% reduced death rate (aRR, 0.35; 95% CI, 0.15−0.79).Conclusion: Patients given Paxlovid showed a lower rate of severe illness or death and alower fatality rate than those who did not receive Paxlovid. Patients who received 3 dosesof the vaccine had a lower rate of severe illness or death and a lower fatality rate than theunvaccinated group.
Original Articles
Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey
June Fei Wen Lau, Yuan Liang Woon, Chin Tho Leong, Hoon Shien Teh
Osong Public Health Res Perspect. 2021;12(6):361-373.   Published online November 25, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0085
  • 8,958 View
  • 446 Download
  • 7 Citations
AbstractAbstract PDFSupplementary Material
Objectives
The coronavirus disease 2019 (COVID-19) pandemic has set a precedent for the fastest-produced vaccine as a result of global collaboration and outreach. This study explored Malaysians’ acceptance of the COVID-19 vaccine and its associated factors.
Methods
A cross-sectional anonymous web-based survey was disseminated to Malaysian adults aged ≥18 years old via social media platforms between July 10, 2020 and August 31, 2020.
Results
In the analysis of 4,164 complete responses, 93.2% of participants indicated that they would accept the COVID-19 vaccine if it was offered for free by the Malaysian government. The median out-of-pocket cost that participants were willing to pay for a COVID-19 vaccine was Malaysian ringgit (MYR) 100 (interquartile range [IQR], 100) if it was readily available and MYR 150 (IQR, 200) if the supply was limited. Respondents with a low likelihood of vaccine hesitancy had 13 times higher odds of accepting the COVID-19 vaccine (95% confidence interval [CI], 8.69 to 19.13). High perceived risk and severity were also associated with willingness to be vaccinated, with adjusted odds ratios of 2.22 (95% CI, 1.44 to 3.41) and 2.76 (95% CI, 1.87 to 4.09), respectively. Age and ethnicity were the only independent demographic characteristics that predicted vaccine uptake.
Conclusion
Public health strategies targeting perceived risk, perceived susceptibility and vaccine hesitancy could be effective in enhancing vaccine uptake.

Citations

Citations to this article as recorded by  
  • Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece
    Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou
    Vacunas.2022; 23: S60.     CrossRef
  • Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework
    Jason Wei Jian Ng, Santha Vaithilingam, Mahendhiran Nair, Li-Ann Hwang, Kamarul Imran Musa, Anat Gesser-Edelsburg
    PLOS ONE.2022; 17(5): e0268926.     CrossRef
  • Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia
    Li Ping Wong, Haridah Alias, Yan-Li Siaw, Mustakiza Muslimin, Lee Lee Lai, Yulan Lin, Zhijian Hu
    Human Vaccines & Immunotherapeutics.2022;[Epub]     CrossRef
  • Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis
    Ayenew Mose, Abebaw Wasie, Solomon Shitu, Kassahun Haile, Abebe Timerga, Tamirat Melis, Tadesse Sahle, Amare Zewdie, Dong Keon Yon
    PLOS ONE.2022; 17(6): e0269273.     CrossRef
  • When do persuasive messages on vaccine safety steer COVID-19 vaccine acceptance and recommendations? Behavioural insights from a randomised controlled experiment in Malaysia
    Nicholas Yee Liang Hing, Yuan Liang Woon, Yew Kong Lee, Hyung Joon Kim, Nurhyikmah M Lothfi, Elizabeth Wong, Komathi Perialathan, Nor Haryati Ahmad Sanusi, Affendi Isa, Chin Tho Leong, Joan Costa-Font
    BMJ Global Health.2022; 7(7): e009250.     CrossRef
  • COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis
    Getaneh Mulualem Belay, Tewodros Getaneh Alemu, Masresha Asmare Techane, Chalachew Adugna Wubneh, Nega Tezera Assimamaw, Tadesse Tarik Tamir, Addis Bilal Muhye, Destaye Guadie Kassie, Amare Wondim, Bewuketu Terefe, Bethlehem Tigabu Tarekegn, Mohammed Seid
    Human Vaccines & Immunotherapeutics.2022;[Epub]     CrossRef
  • Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece
    Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou
    Vacunas (English Edition).2022; 23: S60.     CrossRef
Perceptions of the COVID-19 vaccine and willingness to receive vaccination among health workers in Nigeria
Oluseyi Ademola Adejumo, Olorunfemi Akinbode Ogundele, Cynthia Roli Madubuko, Rosena Olubanke Oluwafemi, Ogochukwu Chinedum Okoye, Kenechukwu Chukwuemeka Okonkwo, Sunday Samson Owolade, Oladimeji Adedeji Junaid, Olutoyin Morenike Lawal, Adenike Christianah Enikuomehin, Maureen Iru Ntaji, Aisha Sokunbi, Aina Omodele Timothy, Olatunji Sunday Abolarin, Emmanuel Olalekan Ali, John Oghenevwirhe Ohaju-Obodo
Osong Public Health Res Perspect. 2021;12(4):236-243.   Published online July 19, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0023
  • 7,762 View
  • 415 Download
  • 23 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
The study aimed to examine health workers’ perceptions of the coronavirus disease 2019 (COVID-19) vaccine in Nigeria and their willingness to receive the vaccine when it becomes available.
Methods
This multi-center cross-sectional study used non-probability convenience sampling to enroll 1,470 hospital workers aged 18 and above from 4 specialized hospitals. A structured and validated self-administered questionnaire was used for data collection. Data entry and analysis were conducted using IBM SPSS ver. 22.0.
Results
The mean age of respondents was 40±6 years. Only 53.5% of the health workers had positive perceptions of the COVID-19 vaccine, and only slightly more than half (55.5%) were willing to receive vaccination. Predictors of willingness to receive the COVID-19 vaccine included having a positive perception of the vaccine (adjusted odds ratio [AOR], 4.55; 95% confidence interval [CI], 3.50−5.69), perceiving a risk of contracting COVID-19 (AOR, 1.50; 95% CI, 1.25–3.98), having received tertiary education (AOR, 3.50; 95% CI, 1.40−6.86), and being a clinical health worker (AOR, 1.25; 95% CI, 1.01−1.68).
Conclusion
Perceptions of the COVID-19 vaccine and willingness to receive the vaccine were sub-optimal among this group. Educational interventions to improve health workers' perceptions and attitudes toward the COVID-19 vaccine are needed.

Citations

Citations to this article as recorded by  
  • Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study
    Rafaella Fortini Queiroz Grenfell, Oyetunde Timothy Oyeyemi
    Pathogens and Global Health.2023; 117(2): 152.     CrossRef
  • Knowledge, attitudes, and factors determining the willingness for COVID-19 vaccination among students in Bangladesh: An online-based cross-sectional study
    Ashis Talukder, Soheli Sharmin, Chuton Deb Nath, Iqramul Haq, Md. Ismail Hossain, Md. Jakaria Habib, Sabiha Shirin Sara
    Journal of Public Health.2023;[Epub]     CrossRef
  • COVID-19 vaccine acceptance prediction: The roles of students’ attitude towards science and mathematics and knowledge of COVID-19 pandemic
    Sunday Ogbu, Ogochukwu Ebere Emenike, Amaka Loretta Nwankwo
    Electronic Journal of Medical and Educational Tech.2023; 16(2): em2304.     CrossRef
  • ‘Why Should I Take the COVID-19 Vaccine after Recovering from the Disease?’ A Mixed-methods Study of Correlates of COVID-19 Vaccine Acceptability among Health Workers in Northern Nigeria
    Zubairu Iliyasu, Muhammad R. Garba, Auwalu U. Gajida, Taiwo G. Amole, Amina A. Umar, Hadiza M. Abdullahi, Aminatu A. Kwaku, Hamisu M. Salihu, Muktar H. Aliyu
    Pathogens and Global Health.2022; 116(4): 254.     CrossRef
  • Suspecting the Figures: What Church Leaders Think About Government’s Commitment to Combating COVID-19 in Nigeria
    Uchechukwu M. Agbo, George C. Nche
    Journal of Asian and African Studies.2022; : 002190962110696.     CrossRef
  • A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review
    Malik Sallam, Mariam Al-Sanafi, Mohammed Sallam
    Journal of Multidisciplinary Healthcare.2022; Volume 15: 21.     CrossRef
  • Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey
    Meliha Cagla Sonmezer, Taha Koray Sahin, Enes Erul, Furkan Sacit Ceylan, Muhammed Yusuf Hamurcu, Nihal Morova, Ipek Rudvan Al, Serhat Unal
    Vaccines.2022; 10(2): 278.     CrossRef
  • Factors influencing COVID-19 vaccine uptake among adults in Nigeria
    Halimat Adedeji-Adenola, Olubusola A. Olugbake, Shakirat A. Adeosun, Ismaeel Yunusa
    PLOS ONE.2022; 17(2): e0264371.     CrossRef
  • Perception and Prevention Practices Relating to Covid 19 Infection Among Elderly in Ogun State, Nigeria
    Adenitire G., Agbede C.O.
    International Journal of Public Health and Pharmac.2022; 2(1): 29.     CrossRef
  • Predicting nursing students' intention to attend face‐to‐face classes on school reopening: A theory of planned behavior application
    Ryan Michael F. Oducado, Jerome V. Cleofas, Gil P. Soriano
    Nursing Forum.2022; 57(5): 733.     CrossRef
  • COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors
    Oluwatosin Olu-Abiodun, Olumide Abiodun, Ngozi Okafor, Nusirat Elelu
    PLOS ONE.2022; 17(5): e0267691.     CrossRef
  • COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis
    Martin Ackah, Louise Ameyaw, Mohammed Gazali Salifu, Delali Pearl Afi Asubonteng, Cynthia Osei Yeboah, Eugene Narkotey Annor, Eunice Abena Kwartemaa Ankapong, Hosea Boakye, Muhammad Shahzad Aslam
    PLOS ONE.2022; 17(5): e0268711.     CrossRef
  • A national survey of COVID-19 vaccine acceptance in Nigeria
    Ahmad Ibrahim Al-Mustapha, Ochulor Okechukwu, Ademola Olayinka, Oyeniyi Rasheed Muhammed, Muftau Oyewo, Samuel A. Owoicho, Ahmed Tijani Abubakar, Abdulsalam Olabisi, Aliyu Jibril, Simon Ereh, Oluwatosin Enoch Fakayode, Oluwaseun Adeolu Ogundijo, Nusirat E
    Vaccine.2022; 40(33): 4726.     CrossRef
  • COVID-19 vaccine hesitancy in Africa: a scoping review
    Betty B. B. Ackah, Michael Woo, Lisa Stallwood, Zahra A. Fazal, Arnold Okpani, Ugochinyere Vivian Ukah, Prince A. Adu
    Global Health Research and Policy.2022;[Epub]     CrossRef
  • COVID-19 Vaccine Acceptance and Associated Factors Among College Students in Dessie City, Northeastern Ethiopia
    Gete Berihun, Zebader Walle, Daniel Teshome, Leykun Berhanu, Mohammed Derso
    Journal of Multidisciplinary Healthcare.2022; Volume 15: 1735.     CrossRef
  • Career Aspiration Fulfillment and COVID-19 Vaccination Intention among Nigerian Youth: An Instrumental Variable Approach
    Abayomi Samuel Oyekale
    International Journal of Environmental Research an.2022; 19(16): 9813.     CrossRef
  • COVID-19 Vaccine Attitude and Its Predictors Among People Living With Chronic Health Conditions in Ibadan, Nigeria
    Lucia Yetunde Ojewale, Rotimi Felix Afolabi, Adesola Ogunniyi
    International Journal of Public Health.2022;[Epub]     CrossRef
  • Associations between COVID-19 vaccine hesitancy and the experience of violence among women and girls living with and at risk of HIV in Nigeria
    Morenike Oluwatoyin Folayan, Olujide Arije, Amaka Enemo, Aaron Sunday, Amira Muhammad, Hasiya Yunusa Nyako, Rilwan Mohammed Abdullah, Henry Okiwu, Erik Lamontagne
    African Journal of AIDS Research.2022; 21(4): 306.     CrossRef
  • Willingness to receive COVID-19 vaccine: A survey among medical radiation workers in Nigeria
    Grace Ben Inah, Samuel Archibong Efanga, Ekaete Vincent Ukpong, Christiana Ifeyinwa Obiora
    Calabar Journal of Health Sciences.2022; 6: 80.     CrossRef
  • Acceptance of COVID-19 vaccine among healthcare workers in Africa, systematic review and meta-analysis
    Zerihun Figa, Tesfaye Temesgen, Addisu Getnet Zemeskel, Moges Ganta, Asrat Alemu, Mesfin Abebe, Zemachu Ashuro
    Public Health in Practice.2022; 4: 100343.     CrossRef
  • Perception and willingness to accept COVID-19 Vaccines: A cross-sectional survey of the general population of Sokoto State, Nigeria
    Oche Mansur Oche, Habibullah Adamu, Musa Yahaya, Hudu Garba Illo, Abdulaziz Mohammad Danmadami, Adamu Ijapa, Asmau Mohammad Wali, Hamza Yusuf, Hafsat Muhammad, Abba Aji, Harapan Harapan
    PLOS ONE.2022; 17(12): e0278332.     CrossRef
  • COVID-19 vaccination acceptance among community members and health workers in Ebonyi state, Nigeria: study protocol for a concurrent-independent mixed method analyses of intention to receive, timeliness of the intention to receive, uptake and hesitancy to
    Ugwu I Omale, Osarhiemen Iyare, Richard L Ewah, Chidinma I Amuzie, Onyinyechukwu U Oka, Victor U Uduma, Azuka S Adeke, Cordis O Ikegwuonu, Olaedo O Nnachi, Okechukwu O Ukpabi, Ifeyinwa M Okeke, Glory E Nkwo, Ugochi IA Nwali
    BMJ Open.2022; 12(12): e061732.     CrossRef
  • Drivers of COVID-19 Vaccine Uptake amongst Healthcare Workers (HCWs) in Nigeria
    Sohail Agha, Adaobi Chine, Mathias Lalika, Samikshya Pandey, Aparna Seth, Alison Wiyeh, Alyssa Seng, Nandan Rao, Akhtar Badshah
    Vaccines.2021; 9(10): 1162.     CrossRef
Brief Report
Isolation and identification of monkeypox virus MPXV-ROK-P1-2022 from the first case in the Republic of Korea
Jin-Won Kim, Minji Lee, Hwachul Shin, Chi-Hwan Choi, Myung-Min Choi, Jee Woong Kim, Hwajung Yi, Cheon-Kwon Yoo, Gi-Eun Rhie
Osong Public Health Res Perspect. 2022;13(4):308-311.   Published online August 31, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0232
  • 2,163 View
  • 97 Download
  • 2 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
Monkeypox outbreaks in nonendemic countries have been reported since early May 2022. The first case of monkeypox in the Republic of Korea was confirmed in a patient who traveled to Europe in June 2022, and an attempt was made to isolate and identify the monkeypox virus (MPXV) from the patient’s specimens.
Methods
Clinical specimens from the patient were inoculated in Vero E6 cells. The isolated virus was identified as MPXV by the observation of cytopathic effects on Vero E6 cells, transmission electron microscopy, conventional polymerase chain reaction (PCR), and sequencing of PCR products.
Results
Cytopathic effects were observed in Vero E6 cells that were inoculated with skin lesion swab eluates. After multiple passages from the primary culture, orthopoxvirus morphology was observed using transmission electron microscopy. In addition, both MPXV-specific (F3L and ATI) and orthopoxvirus-specific genes (A39R, B2R, and HA) were confirmed by conventional PCR and Sanger sequencing.
Conclusion
These results indicate the successful isolation and identification of MPXV from the first patient in the Republic of Korea. The isolated virus was named MPXV-ROK-P1-2022.

Citations

Citations to this article as recorded by  
  • Epidemiological, Clinical, and Virological Investigation of the First Four Cases of Monkeypox in Cartagena during the 2022 Outbreak
    Steev Loyola, Mashiel Fernández-Ruiz, Doris Gómez-Camargo
    Pathogens.2023; 12(2): 159.     CrossRef
  • Isolation and Characterization of Monkeypox Virus from the First Case of Monkeypox — Chongqing Municipality, China, 2022
    Baoying Huang, Hua Zhao, Jingdong Song, Li Zhao, Yao Deng, Wen Wang, Roujian Lu, Wenling Wang, Jiao Ren, Fei Ye, Houwen Tian, Guizhen Wu, Hua Ling, Wenjie Tan
    China CDC Weekly.2022; 4(46): 1019.     CrossRef
Original Article
Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates
Yongmoon Kim, Bryan Inho Kim, Sangwoo Tak
Osong Public Health Res Perspect. 2022;13(6):424-434.   Published online November 28, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0212
  • 931 View
  • 80 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
Although it is widely used as a measure for mortality, the case fatality rate (CFR) ofcoronavirus disease 2019 (COVID-19) can vary over time and fluctuate for many reasons otherthan viral characteristics. To compare the CFRs of different countries in equal measure, weestimated comparable CFRs after adjusting for multiple covariates and examined the mainfactors that contributed to variability in the CFRs among 21 countries.Methods: For statistical analysis, time-series cross-sectional data were collected from OurWorld in Data, CoVariants.org, and GISAID. Biweekly CFRs of COVID-19 were estimated bypooled generalized linear squares regression models for the panel data. Covariates includedthe predominant virus variant, reproduction rate, vaccination, national economic status,hospital beds, diabetes prevalence, and population share of individuals older than age 65. Intotal, 21 countries were eligible for analysis.Results: Adjustment for covariates reduced variation in the CFRs of COVID-19 across countriesand over time. Regression results showed that the dominant spread of the Omicron variant,reproduction rate, and vaccination were associated with lower country-level CFRs, whereasage, the extreme poverty rate, and diabetes prevalence were associated with higher countrylevel CFRs.Conclusion: A direct comparison of crude CFRs among countries may be fallacious, especiallyin a cross-sectional analysis. Our study presents an adjusted comparison of CFRs over timefor a more proper comparison. In addition, our findings suggest that comparing CFRs amongdifferent countries without considering their context, such as the epidemic phase, medicalcapacity, surveillance strategy, and socio-demographic traits, should be avoided.
Review Article
Carbapenem resistance in critically important human pathogens isolated from companion animals: a systematic literature review
Angie Alexandra Rincón-Real, Martha Cecilia Suárez-Alfonso
Osong Public Health Res Perspect. 2022;13(6):407-423.   Published online December 16, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0033
  • 830 View
  • 70 Download
  • 1 Citations
AbstractAbstract PDF
This study aimed to describe the presence and geographical distribution of Gram-negativebacteria considered critical on the priority list of antibiotic-resistant pathogens publishedby the World Health Organization, including carbapenem-resistant Enterobacteriaceae,carbapenem-resistant Acinetobacter spp., and carbapenem-resistant Pseudomonas aeruginosa.A systematic review of original studies published in 5 databases between 2010 and 2021 wasconducted, including genotypically confirmed carbapenem-resistant isolates obtained fromcanines, felines, and their settings. Fifty-one articles met the search criteria. Carbapenemresistant isolates were found in domestic canines and felines, pet food, and on veterinarymedical and household surfaces. The review found that the so-called “big five”—that is, the5 major carbapenemases identified worldwide in Enterobacterales (New Delhi metallo-βlactamase, active-on-imipenem, Verona integron-encoded metallo-β-lactamase, Klebsiellapneumoniae carbapenemase, and oxacillin [OXA]-48-like)—and the 3 most importantcarbapenemases from Acinetobacter spp. (OXA-23-like, OXA-40-like, and OXA-58-like) hadbeen detected in 8 species in the Enterobacteriaceae family and 5 species of glucose nonfermenting bacilli on 5 continents. Two publications used molecular analysis to confirmcarbapenem-resistant bacteria transmission between owners and dogs. Isolating criticallyimportant human carbapenem-resistant Gram-negative bacteria from domestic canines andfelines highlights the importance of including these animal species in surveillance programsand antimicrobial resistance containment plans as part of the One Health approach.

Citations

Citations to this article as recorded by  
  • The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021

    EFSA Journal.2023;[Epub]     CrossRef
Brief Report
Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020
Ae Kyung Park, Il-Hwan Kim, Junyoung Kim, Jeong-Min Kim, Heui Man Kim, Chae young Lee, Myung-Guk Han, Gi-Eun Rhie, Donghyok Kwon, Jeong-Gu Nam, Young-Joon Park, Jin Gwack, Nam-Joo Lee, SangHee Woo, Jin Sun No, Jaehee Lee, Jeemin Ha, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim
Osong Public Health Res Perspect. 2021;12(1):37-43.   Published online February 23, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.12.1.06
  • 5,656 View
  • 198 Download
  • 17 Citations
AbstractAbstract PDF

Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.

Citations

Citations to this article as recorded by  
  • Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea
    Ae Kyung Park, Il-Hwan Kim, Chae Young Lee, Jeong-Ah Kim, Hyeokjin Lee, Heui Man Kim, Nam-Joo Lee, SangHee Woo, Jaehee Lee, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim
    Annals of Laboratory Medicine.2023; 43(2): 211.     CrossRef
  • A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection
    Heui Man Kim, Eun Ju Lee, Sang Won O, Yong Jun Choi, Hyeokjin Lee, Sae Jin Oh, Jeong-Min Kim, Ae Kyung Park, Jeong-Ah Kim, Chae young Lee, Jong Mu Kim, Hanul Park, Young Joon Park, Jeong-Hee Yu, Eun-Young Kim, Hwa-Pyeong Ko, Eun-Jin Kim
    Viral Immunology.2023;[Epub]     CrossRef
  • Genomic evidence of SARS‐CoV‐2 reinfection in the Republic of Korea
    Ae Kyung Park, Jee Eun Rhee, Il‐Hwan Kim, Heui Man Kim, Hyeokjin Lee, Jeong‐Ah Kim, Chae Young Lee, Nam‐Joo Lee, SangHee Woo, Jaehee Lee, Jin Sun No, Gi‐Eun Rhie, Seong Jin Wang, Sang‐Eun Lee, Young Joon Park, Gemma Park, Jung Yeon Kim, Jin Gwack, Cheon‐K
    Journal of Medical Virology.2022; 94(4): 1717.     CrossRef
  • SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021
    Ae Kyung Park, Il-Hwan Kim, Heui Man Kim, Hyeokjin Lee, Nam-Joo Lee, Jeong-Ah Kim, SangHee Woo, Chae young Lee, Jaehee Lee, Sae Jin Oh, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim
    Emerging Infectious Diseases.2022; 28(2): 415.     CrossRef
  • Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals
    Ji-Young Hwang, Yunhwa Kim, Kyung-Min Lee, Eun-Jeong Jang, Chang-Hoon Woo, Chang-Ui Hong, Seok-Tae Choi, Sivilay Xayaheuang, Jong-Geol Jang, June-Hong Ahn, Hosun Park
    Vaccines.2022; 10(2): 332.     CrossRef
  • Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea
    Jeong-Min Kim, Jee Eun Rhee, Myeongsu Yoo, Heui Man Kim, Nam-Joo Lee, Sang Hee Woo, Hye-Jun Jo, Donghyok Kwon, Sangwon Lee, Cheon Kwon Yoo, Eun-Jin Kim
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Molecular Dynamics Studies on the Structural Stability Prediction of SARS-CoV-2 Variants Including Multiple Mutants
    Kwang-Eun Choi, Jeong-Min Kim, Jee Eun Rhee, Ae Kyung Park, Eun-Jin Kim, Cheon Kwon Yoo, Nam Sook Kang
    International Journal of Molecular Sciences.2022; 23(9): 4956.     CrossRef
  • SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients
    Jee-Soo Lee, Ki Wook Yun, Hyeonju Jeong, Boram Kim, Man Jin Kim, Jae Hyeon Park, Ho Seob Shin, Hyeon Sae Oh, Hobin Sung, Myung Gi Song, Sung Im Cho, So Yeon Kim, Chang Kyung Kang, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Myoung-Don Oh, Eun Hwa Choi
    Virulence.2022; 13(1): 1242.     CrossRef
  • Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant
    Sunhee Lee, Gun Young Yoon, Su Jin Lee, Young-Chan Kwon, Hyun Woo Moon, Yu-Jin Kim, Haesoo Kim, Wooseong Lee, Gi Uk Jeong, Chonsaeng Kim, Kyun-Do Kim, Seong-Jun Kim, Dae-Gyun Ahn, Miguel Angel Martinez
    Microbiology Spectrum.2022;[Epub]     CrossRef
  • Clinical scoring system to predict viable viral shedding in patients with COVID-19
    Sung Woon Kang, Heedo Park, Ji Yeun Kim, Sunghee Park, So Yun Lim, Sohyun Lee, Joon-Yong Bae, Jeonghun Kim, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Sung-Cheol Yun, Man-Seong Park, Sung-Han Kim
    Journal of Clinical Virology.2022; 157: 105319.     CrossRef
  • Model-informed COVID-19 exit strategy with projections of SARS-CoV-2 infections generated by variants in the Republic of Korea
    Sung-mok Jung, Kyungmin Huh, Munkhzul Radnaabaatar, Jaehun Jung
    BMC Public Health.2022;[Epub]     CrossRef
  • Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins
    Sanghoo Lee, Mi-Kyeong Lee, Hyeongkyun Na, Jinwoo Ahn, Gayeon Hong, Youngkee Lee, Jimyeong Park, Yejin Kim, Yun-Tae Kim, Chang-Ki Kim, Hwan-Sub Lim, Kyoung-Ryul Lee
    Gene Reports.2021; 23: 101100.     CrossRef
  • Review of Current COVID-19 Diagnostics and Opportunities for Further Development
    Yan Mardian, Herman Kosasih, Muhammad Karyana, Aaron Neal, Chuen-Yen Lau
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants
    Manish Raturi, Anuradha Kusum, Mansi Kala, Garima Mittal, Anita Sharma, Naveen Bansal
    Transfusion Clinique et Biologique.2021; 28(3): 300.     CrossRef
  • Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2
    Kwang-Eun Choi, Jeong-Min Kim, JeeEun Rhee, Ae Kyung Park, Eun-Jin Kim, Nam Sook Kang
    International Journal of Molecular Sciences.2021; 22(16): 8714.     CrossRef
  • Management following the first confirmed case of SARS-CoV-2 in a domestic cat associated with a massive outbreak in South Korea
    Taewon Han, Boyeong Ryu, Suyeon Lee, Yugyeong Song, Yoongje Jeong, Ilhwan Kim, Jeongmin Kim, Eunjin Kim, Wonjun Lee, Hyunju Lee, Haekyoung Hwang
    One Health.2021; 13: 100328.     CrossRef
  • Genomic epidemiology reveals the reduction of the introduction and spread of SARS-CoV-2 after implementing control strategies in Republic of Korea, 2020
    Jung-Hoon Kwon, Jeong-Min Kim, Dong-hun Lee, Ae Kyung Park, Il-Hwan Kim, Da-Won Kim, Ji-Yun Kim, Noori Lim, Kyeong-Yeon Cho, Heui Man Kim, Nam-Joo Lee, SangHee Woo, Chae Young Lee, Jin Sun No, Junyoung Kim, JeeEun Rhee, Myung-Guk Han, Gi-Eun Rhie, Cheon K
    Virus Evolution.2021;[Epub]     CrossRef
Original Articles
Use of Menstrual Sanitary Products in Women of Reproductive Age: Korea Nurses’ Health Study
Hansol Choi, Nam-Kyoo Lim, Heeja Jung, Oksoo Kim, Hyun-Young Park
Osong Public Health Res Perspect. 2021;12(1):20-28.   Published online February 1, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.12.1.04
  • 6,336 View
  • 193 Download
  • 3 Citations
AbstractAbstract PDFSupplementary Material
Objectives

The use of menstrual hygiene products and its effect on women’s health remains under studied. Patterns of menstrual hygiene product use and the rationale behind choices among Korean women aged 18–45 years were examined.

Methods

This cross-sectional study was a part of the Korea Nurses’ Health Study. A total of 20,613 nurses participated, and 8,658 nurses participated in Module 7 which included a menstrual hygiene products-related survey. The data were collected through the mobile survey using a self-reported questionnaire. Participants’ use of menstrual hygiene products and related characteristics were analyzed using frequency (percentage) or mean (SD).

Results

The most common types of menstrual hygiene products across all age groups were disposable menstrual pads (89.0%), followed by cloth menstrual pads (4.5%), tampons (4.2%), and only 1.6% used a menstrual cup. Disposable menstrual pads were the most common across all age groups, but in those aged under 30 years this was followed by tampon use (6%). The most important criteria when choosing a menstrual hygiene product was comfort for disposable menstrual pads (31.3%) and tampons (41.5%), natural ingredients or organic products for cloth menstrual pads (51.4%), and custom fit for the menstrual cup (50.7%). However, for all menstrual hygiene products (except cloth menstrual pads), there was a higher proportion of anxiety than perception of safety, and low awareness of toxic shock syndrome.

Conclusion

It is important for women to use menstrual hygiene products with confidence. More research is needed to better understand potential health effects of menstrual hygiene products.

Citations

Citations to this article as recorded by  
  • Use and perceptions on reusable and non-reusable menstrual products in Spain: A mixed-methods study
    Laura Medina-Perucha, Tomàs López-Jiménez, Anna Sofie Holst, Constanza Jacques-Aviñó, Jordina Munrós-Feliu, Cristina Martínez-Bueno, Carme Valls-Llobet, Diana Pinzón Sanabria, Mª Mercedes Vicente-Hernández, Anna Berenguera, Muhammad Shahzad Aslam
    PLOS ONE.2022; 17(3): e0265646.     CrossRef
  • Women’s attitudes toward certification logos, labels, and advertisements for organic disposable sanitary pads: results from a multi-city cross-sectional survey
    Hayeon Kim, Jinyoung Jung, Yun-Kyoung Song, Taegwon Chang, Sungmin Park, Jiwon Park, Kyungim Kim
    BMC Women's Health.2022;[Epub]     CrossRef
  • Sanitation and hygiene practices of secondary school students from Mtwara town in Tanzania
    Obadia Kyetuza Bishoge, Ademola Kabir Aremu, Dickson Dare Ajayi, Sayoki Godfrey Mfinanga
    International Journal of Health Promotion and Educ.2022; : 1.     CrossRef
Sex differences in factors associated with prediabetes in Korean adults
Jin Suk Ra
Osong Public Health Res Perspect. 2022;13(2):142-152.   Published online April 22, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0053
  • 1,887 View
  • 45 Download
AbstractAbstract PDF
Objectives
Identifying the factors associated with prediabetes is necessary for the early detection and management of high-risk individuals with prediabetes. The purpose of this study was to identify the factors associated with prediabetes according to sex in Korean adults. Methods: Using the Korean National Health and Nutrition Examination Survey from 2015 to 2019, a total of 13,595 adults (5,565 males and 8,030 females) aged ≥20 years were included in the data analysis. Logistic regression analysis was performed to identify the factors associated with prediabetes according to sex in Korean adults. Results: In both males and females, age and a family history of type 2 diabetes were associated with prediabetes. In males, current and past smoking habits were associated with increased prediabetes. In addition, low-intensity physical activity and prolonged sedentary behavior were associated with a higher prevalence of prediabetes. Females with a lower education level (less than middle school graduation) showed a higher risk of prediabetes. Conclusion: Sex-specific prevention strategies for prediabetes should be developed. In addition, older individuals and those with a family history of type 2 diabetes should be screened for prediabetes.
Review Article
Yersinia pestis antibiotic resistance: a systematic review
Chen Lei, Suresh Kumar
Osong Public Health Res Perspect. 2022;13(1):24-36.   Published online February 18, 2022
DOI: https://doi.org/10.24171/j.phrp.2021.0288
  • 3,317 View
  • 157 Download
  • 3 Citations
AbstractAbstract PDF
Yersinia pestis, the cause of plague and a potential biological weapon, has always been a threatening pathogen. Some strains of Y. pestis have varying degrees of antibiotic resistance. Thus, this systematic review was conducted to alert clinicians to this pathogen’s potential antimicrobial resistance. A review of the literature was conducted for experimental reports and systematic reviews on the topics of plague, Y. pestis, and antibiotic resistance. From 1995 to 2021, 7 Y. pestis isolates with 4 antibiotic resistance mechanisms were reported. In Y. pestis 17/95, 16/95, and 2180H, resistance was mediated by transferable plasmids. Each plasmid contained resistance genes encoded within specific transposons. Strain 17/95 presented multiple drug resistance, since plasmid 1202 contained 10 resistance determinants. Strains 16/95 and 2180H showed single antibiotic resistance because both additional plasmids in these strains carried only 1 antimicrobial determinant. Strains 12/87, S19960127, 56/13, and 59/13 exhibited streptomycin resistance due to an rpsl gene mutation, a novel mechanism that was discovered recently. Y. pestis can acquire antibiotic resistance in nature not only via conjugative transfer of antimicrobial-resistant plasmids from other bacteria, but also by gene point mutations. Global surveillance should be strengthened to identify antibiotic-resistant Y. pestis strains by whole-genome sequencing and drug susceptibility testing.

Citations

Citations to this article as recorded by  
  • Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
    Moshe Aftalion, Avital Tidhar, Yaron Vagima, David Gur, Ayelet Zauberman, Tzvi Holtzman, Arik Makovitzki, Theodor Chitlaru, Emanuelle Mamroud, Yinon Levy
    Vaccines.2023; 11(3): 581.     CrossRef
  • A situation analysis of the current plague outbreak in the Demographic Republic of Congo and counteracting strategies – Correspondence
    Ranjit Sah, Abdullah Reda, Rachana Mehta, Ranjan K. Mohapatra, Kuldeep Dhama
    International Journal of Surgery.2022; 105: 106885.     CrossRef
  • Antimicrobial resistance in Klebsiella pneumoniae: identification of bacterial DNA adenine methyltransferase as a novel drug target from hypothetical proteins using subtractive genomics
    Umairah Natasya Mohd Omeershffudin, Suresh Kumar
    Genomics & Informatics.2022; 20(4): e47.     CrossRef
Original Article
Effects of activities of daily living-based dual-task training on upper extremity function, cognitive function, and quality of life in stroke patients
Hee-Su An, Deok-Ju Kim
Osong Public Health Res Perspect. 2021;12(5):304-313.   Published online September 13, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0177
  • 8,196 View
  • 205 Download
  • 1 Citations
AbstractAbstract PDFSupplementary Material
Objectives
The aim of this study was to investigate the effect of daily living dual-task training focused on improving attention and executive function of the upper extremities, cognitive function, and quality of life in stroke patients.
Methods
We included 30 stroke patients who were hospitalized between July 2020 and October 2020. They were divided into experimental and control groups through randomization. The experimental group performed 20 minutes of dual-task training and received 10 minutes of conventional occupational therapy, while the control group performed 20 minutes of single-task training and received 10 minutes of conventional occupational therapy. Both groups underwent their respective rehabilitation for 30 minutes per session, 5 times per week for 5 weeks.
Results
Both groups showed significant improvements in upper extremity function, cognitive function, and quality of life; the experimental group showed higher results for all items. A significant between-group difference was observed in the magnitude of the changes.
Conclusion
In stroke patients, dual-task training that combined attention and executive function with daily living activities was found to be meaningful, as it encouraged active participation and motivation. This study is expected to be used as a foundation for future interventions for stroke patients.

Citations

Citations to this article as recorded by  
  • Effect of Upper Limb Motor Rehabilitation on Cognition in Parkinson’s Disease: An Observational Study
    Valentina Varalta, Elisa Evangelista, Anna Righetti, Giovanni Morone, Stefano Tamburin, Alessandro Picelli, Cristina Fonte, Michele Tinazzi, Ilaria Antonella Di Vico, Andreas Waldner, Mirko Filippetti, Nicola Smania
    Brain Sciences.2022; 12(12): 1684.     CrossRef
Brief Report
COVID-19 Pandemic in Hong Kong and Gaza Strip: Lessons Learned from Two Densely Populated Locations in the World
Hammoda Abu-Odah, Sheena Ramazanu, Eslam Saleh, Jonathan Bayuo, Yehia Abed, Motasem Said Salah
Osong Public Health Res Perspect. 2021;12(1):44-50.   Published online February 23, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.12.1.07
  • 5,246 View
  • 103 Download
  • 4 Citations
AbstractAbstract PDF

The emergence of the coronavirus pandemic led to the implementation of several precautionary measures across the globe. For densely populated regions in the world, this may have been challenging given the proximity of people to one other. Thus, this brief report sought to compare the measures across 2 densely populated locations, Hong Kong and Gaza. Epidemiological data was obtained from governmental online repositories and was compared with the data presented by the Johns Hopkins coronavirus map to ensure consistency. Descriptive statistics were used to interpret the data obtained over the period of the study. The data suggested that although Hong Kong and Gaza implemented similar strategies, Gaza recorded marginally higher cases compared with Hong Kong in the same timeframe. The strategies implemented in both settings included border closures, social distancing, proper hand hygiene, and mask usage. Cultural and socio-demographic differences may have played a part in this variation in case numbers, in addition to lessons Hong Kong had previously learned from a similar outbreak. As the pandemic is ongoing it is essential that public sensitization to adherence to precautionary measures at the personal/family level does not occur.

Citations

Citations to this article as recorded by  
  • The Effectiveness of Electrical Vestibular Stimulation (VeNS) on Symptoms of Anxiety: Study Protocol of a Randomized, Double-Blinded, Sham-Controlled Trial
    Teris Cheung, Joyce Yuen Ting Lam, Kwan Hin Fong, Yuen Shan Ho, Alex Ho, Calvin Pak-Wing Cheng, Julie Sittlington, Yu-Tao Xiang, Tim Man Ho Li
    International Journal of Environmental Research an.2023; 20(5): 4218.     CrossRef
  • Unwillingness or reluctance of Palestinians to get the COVID-19 vaccine: the reasons behind it and how to persuade them
    Hammoda Abu-Odah, Jing Su, Salihu Sabiu Musa
    International Journal of Infectious Diseases.2022; 119: 53.     CrossRef
  • Palliative Care Landscape in the COVID-19 Era: Bibliometric Analysis of Global Research
    Hammoda Abu-Odah, Jingjing Su, Mian Wang, Sin-Yi (Rose) Lin, Jonathan Bayuo, Salihu Sabiu Musa, Alex Molassiotis
    Healthcare.2022; 10(7): 1344.     CrossRef
  • Readiness and determinants of Vietnam's general public to receive the COVID-19 Vaccine: a national online cross-sectional study
    Huong Thi Xuan Hoang, Hammoda Abu-Odah, Anh Hoang Vu, Liep Van Nguyen
    F1000Research.2022; 11: 715.     CrossRef
Review Article
Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children
Milad Zandi, Saber Soltani, Mona Fani, Samaneh Abbasi, Saeedeh Ebrahimi, Ali Ramezani
Osong Public Health Res Perspect. 2021;12(5):286-292.   Published online October 1, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0140
  • 4,567 View
  • 148 Download
  • 5 Citations
AbstractAbstract PDF
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has infected many people around the world. Children are considered an important target group for SARS-CoV-2, as well as other viral infections such as respiratory syncytial virus infection. Both SARS-CoV-2 and respiratory syncytial virus can affect the respiratory tract. Coinfection of SARS-CoV-2 and respiratory syncytial virus can pose significant challenges in terms of diagnosis and treatment in children. This review compares the symptoms, diagnostic methods, and treatment of COVID-19 and respiratory syncytial virus infection in children.

Citations

Citations to this article as recorded by  
  • Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020
    Thomas Williams, Sandra Jackson, Ian Barr, Shabana Bi, Jinal Bhiman, Joanna Ellis, Anne von Gottberg, Stephen Lindstrom, Teresa Peret, Sanjiv Rughooputh, Mariana Viegas, Siddhivinayak Hirve, Maria Zambon, Wenqing Zhang, Ndongo Dia, Norosoa Razanazatovo, A
    Influenza and Other Respiratory Viruses.2023;[Epub]     CrossRef
  • The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections
    Ashley Losier, Gayatri Gupta, Mario Caldararo, Charles S. Dela Cruz
    Clinics in Chest Medicine.2023;[Epub]     CrossRef
  • Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions
    Elly Binns, Jane Tuckerman, Paul V Licciardi, Danielle Wurzel
    Journal of Paediatrics and Child Health.2022; 58(10): 1741.     CrossRef
  • Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children
    Laura Elena Córdova-Dávalos, Alicia Hernández-Mercado, Claudia Berenice Barrón-García, Augusto Rojas-Martínez, Mariela Jiménez, Eva Salinas, Daniel Cervantes-García
    Virus Genes.2022; 58(6): 501.     CrossRef
  • Clinical and epidemiological characteristics of SARS-CoV-2 virus in ambulatory children under 2 years old
    Carolina A. Perez, Ivana Ormazabal, Javier Pérez-Valenzuela, Andrea Araya, Rafael A. Medina, Cecilia Perret
    Frontiers in Pediatrics.2022;[Epub]     CrossRef
Special Article
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi
Osong Public Health Res Perspect. 2023;14(1):5-14.   Published online February 28, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0026
  • 492 View
  • 36 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication. The CoVaSC mainly utilizes pseudonymized data linking KDCA’s COVID-19 vaccination data and the National Health Insurance Service’s claims data. The CoVaSC’s 5-step research process involves defining the target diseases and organizing ad-hoc committees, developing research protocols, performing analyses, assessing causal relationships, and announcing research findings and utilizing them to guide compensation policies. As of 2022, the CoVaSC completed this research process for 15 adverse events. The CoVaSC launched the COVID-19 Vaccine Safety Research Center in September 2022 and has been reorganized into 4 divisions to promote research including international collaborative studies, long-/short-term follow-up studies, and education programs. Through these enhancements, the CoVaSC will continue to swiftly provide scientific evidence for COVID-19 vaccine research and compensation and may serve as a model for preparing for future epidemics of new diseases.

PHRP : Osong Public Health and Research Perspectives